C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/04 (2006.01) A61K 31/4164 (2006.01) A61K 31/4192 (2006.01) A61K 31/42 (2006.01) A61K 31/4245 (2006.01) A61K 31/454 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) C07D 233/54 (2006.01) C07D 249/06 (2006.01) C07D 263/32 (2006.01) C07D 271/06 (2006.01) C07D 401/02 (2006.01) C07D 413/02 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2490972
Compounds are provided which are useful as antidiabetic agents and antiobesity agents and have the structure (I) wherein m is 0, 1 or 2; n is 0, 1 or 2; Q is C or N; A is (CH~2)x where x is 1 to 5, or A is (CH~2)x1 where x1~ is 1 to 5 with an alkenyl bond or an alkynyl bond embedded anywhere in the chain, or A is -(CH~2)x2~-O-(CH~2)x3~- where x2~ is 0 to 5 and x3~ is 0 to 5, provided that at least one of x2~ and x3~ is other than 0; B is a bond or is (CH~2)x4~ where x4~ is 1 to 5; X is CH or N; X~2 is C, N, O or S; X~3 is C, N, O or S; X~4 is C, N, O or S; X~5 is C, N, O or S; X~6 is C, N, O or S; provided that at least one of X~2, X~3, X~4 X~5 and X~6 is N; and at least one of X~2, X~3, X~4, X~5 and X~6 is C, and specifically excluding the structure (II) where X~2 = N, X~3 = C, X~4 = O or S, Z = o or a bond; R1~ is H or alkyl; R2~ is H, alkyl, alkoxy, halogen, amino or substituted amino or cyano; R2a~, R2b~ and R2c~ may be the same or different and are selected from H, alkyl, alkoxy, halogen, amino or substituted amino or cyano; and R3~ and Y are as defined herein, which compounds are useful in treating diabetes and obesity.
L'invention porte sur des compos~s qui sont utiles comme agents antidiab~tiques et agents anti-ob~sit~ et qui ont la structure (I) dans laquelle m vaut 0, 1 ou 2; n vaut 0, 1 ou 2; Q repr~sente C ou N; A repr~sente (CH´2?)x, x valant de 1 ~ 5, ou A repr~sente (CH´2?)x?1´, x?1´ valant de 1 ~ 5 avec une liaison alc~nyle ou une liaison alkynyle imbriqu~e ~ n'importe quel endroit de la cha¹ne, ou A repr~sente -(CH´2?)x?2´-O-(CH´2?)x?3´-, x?2´ valant de 0 ~ 5 et x?3´ de 0 ~ 5, ~ condition qu'au moins un de x?2´ et de x?3´ soit diff~rent de 0; B repr~sente une liaison ou repr~sente (CH´2?)x?4´, x?4´ valant de 1 ~ 5; X repr~sente CH ou N; X´2? repr~sente C, N, O ou S; X´3? repr~sente C, N, O ou S; X´4? repr~sente C, N, O ou S; X´5? repr~sente C, N, O ou S; X´6? repr~sente C, N, O ou S; ~ condition qu'au moins un de X´2?, X´3?, X´4? X´5? et X´6? repr~sente N; et qu'au moins un de X´2?, X´3?, X´4?, X´5? et X´6? repr~sente C, et sp~cifiquement excluant la structure (II) dans laquelle X´2? = N, X´3? = C, X´4? = O ou S, Z = o ou une liaison; R?1´ repr~sente H ou alkyle; R?2´ repr~sente H, alkyle, alcoxy, halogne, amino ou amino substitu~ ou cyano; R?2a´, R?2b´ et R?2c´ peuvent Útre identiques ou diff~rents et sont s~lectionn~s parmi H, alkyle, alcoxy, halogne, amino ou amino substitu~ ou cyano; et R?3´ et Y son tels que d~finis dans le descriptif. Ces compos~s sont utiles dans le traitement du diabte et de l'ob~sit~.
Chen Sean
Cheng Peter T. W.
Ding Charles Z.
Herpin Timothy F.
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Substituted heterocyclic derivatives useful as antidiabetic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted heterocyclic derivatives useful as antidiabetic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heterocyclic derivatives useful as antidiabetic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1628779